Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation

L. Fialova, A. Bartos, J. Svarcova

. 2017 ; 161 (3) : 286-295. [pub] 20170925

Language English Country Czech Republic

Document type Journal Article

AIMS: The aim of this study was to evaluate the diagnostic potential of cerebrospinal fluid (CSF) and serum levels of neurocytoskeletal proteins and their ratios for the diagnosis of dementias and to assess the differences in neurocytoskeletal proteins between neurodegeneration and neuroinflammation. METHODS: CSF and serum levels of neurofilament light subunits (NFL) and neurofilament heavy subunits (NFH) as well as CSF levels of total tau (t-tau) and phosphorylated tau (p-tau) proteins were determined using ELISA in 20 Alzheimer's disease patients (AD group), 13 patients with other dementias (OD group), 17 patients with inflammatory aseptic neuro-infections (IP), and 20 aged-matched cognitively normal elderly persons (NC group). RESULTS: The ratio CSF p-tau/t-tau was significantly higher in the NC group than that in the AD or OD groups (P<0.0005 for each group). The CSF NFH/p-tau and CSF NFL/p-tau ratios were significantly lower in AD patients than OD patients (P≤0.003). Serum and CSF NFL and CSF NFH levels were significantly higher in OD patients than AD patients (P≤0.03). The lowest values of the CSF NFL/NFH ratio were found in the IP group and they significantly differed from those in normal controls (P<0.0001) and any dementia group (IP vs. AD P<0.0001; IP vs. OD P=0.03). CONCLUSION: CSF tau proteins and their index differentiated between AD or OD patients and cognitively normal subjects, while CSF levels of neurofilaments expressed as their index seem to contribute to the discrimination between patients with neuroinflammation and normal controls or AD patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025558
003      
CZ-PrNML
005      
20201204090420.0
007      
ta
008      
180711s2017 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2017.038 $2 doi
035    __
$a (PubMed)28947837
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Fialova, Lenka $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
245    10
$a Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation / $c L. Fialova, A. Bartos, J. Svarcova
520    9_
$a AIMS: The aim of this study was to evaluate the diagnostic potential of cerebrospinal fluid (CSF) and serum levels of neurocytoskeletal proteins and their ratios for the diagnosis of dementias and to assess the differences in neurocytoskeletal proteins between neurodegeneration and neuroinflammation. METHODS: CSF and serum levels of neurofilament light subunits (NFL) and neurofilament heavy subunits (NFH) as well as CSF levels of total tau (t-tau) and phosphorylated tau (p-tau) proteins were determined using ELISA in 20 Alzheimer's disease patients (AD group), 13 patients with other dementias (OD group), 17 patients with inflammatory aseptic neuro-infections (IP), and 20 aged-matched cognitively normal elderly persons (NC group). RESULTS: The ratio CSF p-tau/t-tau was significantly higher in the NC group than that in the AD or OD groups (P<0.0005 for each group). The CSF NFH/p-tau and CSF NFL/p-tau ratios were significantly lower in AD patients than OD patients (P≤0.003). Serum and CSF NFL and CSF NFH levels were significantly higher in OD patients than AD patients (P≤0.03). The lowest values of the CSF NFL/NFH ratio were found in the IP group and they significantly differed from those in normal controls (P<0.0001) and any dementia group (IP vs. AD P<0.0001; IP vs. OD P=0.03). CONCLUSION: CSF tau proteins and their index differentiated between AD or OD patients and cognitively normal subjects, while CSF levels of neurofilaments expressed as their index seem to contribute to the discrimination between patients with neuroinflammation and normal controls or AD patients.
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $x mok mozkomíšní $7 D015415
650    _2
$a demence $x krev $x mok mozkomíšní $x patologie $7 D003704
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x krev $x mok mozkomíšní $x patologie $7 D007249
650    _2
$a intermediární filamenta $7 D007382
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a neurofilamentové proteiny $x krev $x mok mozkomíšní $7 D016900
650    _2
$a bílá hmota $7 D066127
650    _2
$a proteiny tau $x krev $x mok mozkomíšní $7 D016875
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bartoš, Aleš $u National Institute of Mental Health, Klecany, Czech Republic; Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $7 xx0028753
700    1_
$a Švarcová, Jana $u Department of Medical Chemistry and Clinical Biochemistry, Motol University Hospital, Prague, Czech Republic $7 xx0101454
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 161, č. 3 (2017), s. 286-295
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28947837 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20180711 $b ABA008
991    __
$a 20201204090418 $b ABA008
999    __
$a ok $b bmc $g 1324892 $s 1022480
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 161 $c 3 $d 286-295 $e 20170925 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20180711

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...